Conference Schedule
- Day 1
- Day 2
- Day 3
Keynote Presentation (In-Person)
Title : Hypoxic Glycolysis Controls Cancers, Pathogens and immunity - Genetic deconstruction and therapeutic perspectives
Jacques Pouyssegur, University of Nice, France
Keynote Presentation (Virtual)
Title : Sensor-Based Detection of Biomarkers for Early-stage Ovarian Cancer
Michael Thompson, University of Toronto, Canada
Keynote Presentation (In-Person)
Title : Exosome-based BALF liquid biopsy (ExoBAL) for EGFR mutation testing in NSCLC patients
Kye Young Lee, Konkuk University Medical Center, South Korea
Keynote Presentation (Virtual)
Title : Photodynamic therapy for healing radiation-induced skin ulcers: the first Canadian documented clinical case
Patricia Tai, University of Saskatchewan, Canada
Keynote Presentation (Virtual)
Title : Open abdomen and negative pressure wound therapy for acute peritonitis especially in the presence of anastomoses and ostomies
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Keynote Presentation (Virtual)
Title : Upfront surgery with adjuvant treatment in operable triple negative breast cancer patient-A single institute experience
Manmohan Agrawal, Pushpadi Cancer Care Centre, India
Oral Presentation (In-Person)
Title : Time to change to time: Single amino acid resolution anti-tumor platform Tag-Tack is standby
Jun Bai, Shaanxi Provincial People's Hosptital, China
Oral Presentation (In-Person)
Title : New thiophene derivative blocking TLR4/MAPK pathway sensitizes hepatocellular carcinoma induced in rats to Ionizing radiation and convince apoptosis through JAK/STAT3, β-Catenin/NOTCH and SOCS3 downstream Nrf2, PPAR-γ signalling
Nermeen M. ElBakary, Egyptian atomic energy authority, Egypt
Oral Presentation (In-Person)
Title : Nanolipids derived from plasma of animal models, an optimal method for delivering gene silencers in glioblastoma model
Amir Monfaredan, Tehran University of Medical Sciences, Iran
Poster Presentation (In-Person)
Title : Functionalized amygdalin-nano enhances chemo‑ and radio‑sensitivity by targeting P38/MAPK immunomodulators signaling in breast cancer cells
Rokaya Elsayed Maarouf, Egyptian atomic energy authority, Egypt
Oral Presentation (In-Person)